无创正压通气在急性心力衰竭中的临床应用

陈开祥; 周新华; 孙成爱

doi:10.13898/j.cnki.issn.1000-2200.2016.01.008

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

无创正压通气在急性心力衰竭中的临床应用

陈开祥 , 周新华 , 孙成爱

文章导航 > 蚌埠医学院学报 > 2016, 41 > 1: (32-34)

引用本文:

Citation:

无创正压通气在急性心力衰竭中的临床应用

江苏省连云港市第二人民医院急诊重症监护病房, 222006

作者简介: 陈开祥(1973-),男,硕士,副主任医师.

基金项目:
蚌埠医学院科学研究项目(Byky1284NF)
中图分类号: R541.6

The clinical application of the noninvasive positive pressure ventilation in acute heart failure

Department of Emergency Intensive Care Unit, The Second People's Hospital of Lianyungang, Lianyungang Jiangsu 222006, China
CLC number: R541.6

摘要: 目的:评价无创正压通气(NIPPV)治疗急性心力衰竭(AHF)的效果。方法:将60例AHF患者随机分为2组,对照组采用常规抗心力衰竭治疗;治疗组除常规治疗外加用NIPPV治疗。观察2组患者治疗前、治疗2 h和8 h后的临床表现及心率(HR)、呼吸频率(RR)、平均动脉压(MAP)、中心静脉压(CVP)、动脉血气等变化。随访出院后6个月内因心力衰竭再次发作住院情况。结果:治疗组患者在NIPPV后心功能明显改善,治疗效果高于对照组(P<0.05);2组患者治疗2 h和8 h后的HR、RR、动脉血氧分压(PaO₂)与血氧饱和度(SaO₂)均优于治疗前(P<0.01)。治疗组治疗前、治疗2 h和8 h后二氧化碳分压与对照组差异均无统计学意义(P>0.05);PaO₂、SaO₂、CVP较对照组升高(P<0.05~P<0.01);HR、RR和MAP均较对照组下降(P<0.05~P<0.01)。随访6个月内2组因再次心力衰竭发作住院率差异无统计学意义(P>0.05)。结论:NIPPV可明显改善AHF的低氧血症和心功能,是救治AHF的一种安全有效的方法。
- 心力衰竭 /
- 无创正压通气 /
- 心源性肺水肿
Abstract: Objective:To evaluated the clinical effects of the noninvasive positive pressure ventilation(NIPPV) in the treatment of acute heart failure(AHF).Methods:Sixty patients with AHF were randomly divided into the control group and treatment group.The control group were treated with routine anti-heart failure therapy, and the treatment group were treated with NIPPV combined with routine therapy.The changes of clinical symptoms, heart rate(HR), respiratory rate(RR), mean arterial pressure(MAP), central venous pressure(CVP), arterial blood gas [partial pressure of oxygen(PaO₂), partial pressure of oxygen(PaCO₂) and oxygen saturation(SaO₂)] in two groups were observed before treatment and after 2 and 8 hours of treatment.The rehospitalization conditions of patients caused by heart failure were followed up after 6 months of discharge.Results:The cardiac function in treatment group treated with NIPPV was significantly improved, the effect of which was better than that in control group(P<0.05).After 2 and 8 hours of therapy, the levels of HR, RR, PaO₂ and SaO₂ in treatment group were better than those in control group(P<0.01).The difference of the PaCO₂ level in treatment group between before treatment and after 2 and 8 hours of therapy was not statistically significant(P>0.05).Compared with the control group, the levels of PaO₂, SaO₂ and CVP in treatment group increased(P<0.05 to P<0.01), and the levels of HR, RR and MAP in treatment group decreased(P<0.05 to P<0.01).The difference of the rehospitalization rate between two groups caused by heart failure was not statistically significant during the six months of following-up(P>0.05).Conclusions:NIPPV can obviously improve the hypoxemia and cardiac function in patients with AHF, which is a kind of safe and effective method in the treatment of AHF.
- heart failure /
- noninvasive positive pressure ventilation /
- cardiogenic pulmonary edema

[1]	MCMURRAY JJ, ADAMOPOULOS S, ANKER D, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012;The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association(HFA) of the ESC[J]. Eur Heart J,2012,33(14):1787.
[2]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 急性心力衰竭诊断和治疗指南[J]. 中华心血管病杂志,2010, 38(3):195.
[3]	WENG CL,ZHOU YT,LIU QH,et al. Meta-analysis:Noninvasive ventilation in acute cardiogenic pulmonary edema[J]. Ann Intem Med,2010,152(9):590.
[4]	MARIANI J, MACCHINA A, BELZITI C, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema:a meta-analysis of randomized controlled trials[J]. J Card Fail,2011,17(10):850.
[5]	GRAY AJ, GOODACRE S, NEWBY DE, et al. A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema:the 3CPO trial[J]. Health Technol Assess,2009,13(33):101.
[6]	李忠元,但传军,徐僖,等. 机械通气在急性左心衰竭中的应用[J]. 中国老年学杂志,2010,30(23):3602.

[1]	刘春艳 , 朱昊平 , 余跃天 . 早期重组人脑利钠肽联合无创正压通气治疗急性失代偿性心力衰竭疗效观察. 蚌埠医学院学报, 2014, 38(1): 43-46.
[2]	田庾 . 无创正压通气治疗急性心源性肺水肿临床分析. 蚌埠医学院学报, 2010, 35(6): 597-598,601.
[3]	钱朝霞 , 竟雪莹 , 方陈 , 高忠和 . 无创正压通气治疗老年重症急性心源性肺水肿的疗效观察. 蚌埠医学院学报, 2009, 34(3): 201-204.
[4]	伍德生 , 李殿明 , 吴晓飞 . 无创正压通气治疗慢性阻塞性肺病伴呼吸衰竭疗效观察. 蚌埠医学院学报, 2011, 36(9): 956-958.
[5]	钱叶长 , 危蕾 , 刘芳英 , 申燕华 , 周丽萍 . 支气管冲洗术联合无创正压通气治疗老年人慢性阻塞性肺疾病并Ⅱ型呼吸衰竭. 蚌埠医学院学报, 2011, 36(9): 964-967.
[6]	夏雪梅 , 陈余清 , 刘超 , 胡俊锋 , 李殿明 , 李伟 . 无创正压通气在慢性阻塞性肺疾病急性加重并发呼吸衰竭中的应用及影响治疗因素分析. 蚌埠医学院学报, 2009, 34(9): 769-772.
[7]	钱朝霞 , 高中和 . 无创正压通气治疗老年性早期肺性脑病疗效分析. 蚌埠医学院学报, 2005, 30(1): 43-45.
[8]	赵翠英 , 刘永刚 , 连俊勤 , 邹起瑞 , 彭檀 . 上气道狭窄部位手术配合持续气道内正压通气治疗阻塞性睡眠呼吸暂停综合征临床分析. 蚌埠医学院学报, 2011, 36(6): 594-595.
[9]	张爱雄 . 多巴胺持续泵入治疗顽固性心力衰竭的疗效观察. 蚌埠医学院学报, 2013, 37(9): 1146-1147.
[10]	张学强 . 危重症患者心力衰竭的危险因素分析. 蚌埠医学院学报, 2017, 42(2): 212-214. doi: 10.13898/j.cnki.issn.1000-2200.2017.02.024
[11]	蔡长霞 , 甘桂芬 , 牛毅 , 赵海燕 . 老年心力衰竭合并肺部感染病人病原学分析及预后. 蚌埠医学院学报, 2019, 44(3): 363-365. doi: 10.13898/j.cnki.issn.1000-2200.2019.03.024
[12]	赵德生 , 佘强 . 脑钠肽和氨基末端脑钠肽前体在心力衰竭中的应用. 蚌埠医学院学报, 2008, 33(1): 121-123.
[13]	黄涛 , 程仁力 . 坎地沙坦对冠心病心力衰竭患者心室重塑及心功能的影响. 蚌埠医学院学报, 2010, 35(9): 914-916.
[14]	张克良 , 孟令民 , 刘大成 , 贾凤玖 , 徐媛 , 徐淑丽 . 多巴胺、多巴酚丁胺、门冬氨酸钾镁、呋塞米合用治疗顽固性心力衰竭临床观察. 蚌埠医学院学报, 2014, 39(10): 1383-1385.
[15]	王浩 , 李霞 , 林良毅 , 王萍 , 林少华 . 降钙素原对左心室射血分数正常心力衰竭患者病情预后判断价值. 蚌埠医学院学报, 2015, 40(3): 348-350. doi: 10.13898/j.cnki.issn.1000-2200.2015.03.017
[16]	徐晓飞 . 连续性肾脏替代治疗联合新活素治疗顽固性心力衰竭的效果分析. 蚌埠医学院学报, 2017, 42(5): 609-611,615. doi: 10.13898/j.cnki.issn.1000-2200.2017.05.014
[17]	陈美霞 , 梁冰 . BNP、CRP、D-D联合检测对评估高龄房颤合并心力衰竭病人的临床意义. 蚌埠医学院学报, 2017, 42(8): 1048-1050. doi: 10.13898/j.cnki.issn.1000-2200.2017.08.011
[18]	刘发军 , 薛礼 , 陈鸿武 , 张磊 . 心率变异性联合NT-proBNP对心力衰竭病人再入院率的预测价值. 蚌埠医学院学报, 2019, 44(9): 1166-1169. doi: 10.13898/j.cnki.issn.1000-2200.2019.09.007
[19]	薛礼 , 刘瑶 , 张磊 , 孔祥勇 , 陈鸿武 . 心脏康复对慢性心力衰竭病人心功能及生活质量的影响. 蚌埠医学院学报, 2021, 46(8): 1083-1086. doi: 10.13898/j.cnki.issn.1000-2200.2021.08.024
[20]	吴华清 , 严激 . 心脏再同步化治疗心力衰竭的死亡原因分析. 蚌埠医学院学报, 2008, 33(5): 518-520.

点击查看大图

计量

文章访问数: 3163
HTML全文浏览量: 388
PDF下载量: 159
被引次数: 0

无创正压通气在急性心力衰竭中的临床应用

作者简介: 陈开祥(1973-),男,硕士,副主任医师.

江苏省连云港市第二人民医院急诊重症监护病房, 222006

收稿日期: 2015-03-25

基金项目: 蚌埠医学院科学研究项目(Byky1284NF)

关键词:

摘要: 目的:评价无创正压通气(NIPPV)治疗急性心力衰竭(AHF)的效果。方法:将60例AHF患者随机分为2组,对照组采用常规抗心力衰竭治疗;治疗组除常规治疗外加用NIPPV治疗。观察2组患者治疗前、治疗2 h和8 h后的临床表现及心率(HR)、呼吸频率(RR)、平均动脉压(MAP)、中心静脉压(CVP)、动脉血气等变化。随访出院后6个月内因心力衰竭再次发作住院情况。结果:治疗组患者在NIPPV后心功能明显改善,治疗效果高于对照组(P<0.05);2组患者治疗2 h和8 h后的HR、RR、动脉血氧分压(PaO₂)与血氧饱和度(SaO₂)均优于治疗前(P<0.01)。治疗组治疗前、治疗2 h和8 h后二氧化碳分压与对照组差异均无统计学意义(P>0.05);PaO₂、SaO₂、CVP较对照组升高(P<0.05~P<0.01);HR、RR和MAP均较对照组下降(P<0.05~P<0.01)。随访6个月内2组因再次心力衰竭发作住院率差异无统计学意义(P>0.05)。结论:NIPPV可明显改善AHF的低氧血症和心功能,是救治AHF的一种安全有效的方法。

English Abstract

The clinical application of the noninvasive positive pressure ventilation in acute heart failure

Department of Emergency Intensive Care Unit, The Second People's Hospital of Lianyungang, Lianyungang Jiangsu 222006, China

Received Date: 2015-03-25

Abstract: Objective:To evaluated the clinical effects of the noninvasive positive pressure ventilation(NIPPV) in the treatment of acute heart failure(AHF).Methods:Sixty patients with AHF were randomly divided into the control group and treatment group.The control group were treated with routine anti-heart failure therapy, and the treatment group were treated with NIPPV combined with routine therapy.The changes of clinical symptoms, heart rate(HR), respiratory rate(RR), mean arterial pressure(MAP), central venous pressure(CVP), arterial blood gas [partial pressure of oxygen(PaO₂), partial pressure of oxygen(PaCO₂) and oxygen saturation(SaO₂)] in two groups were observed before treatment and after 2 and 8 hours of treatment.The rehospitalization conditions of patients caused by heart failure were followed up after 6 months of discharge.Results:The cardiac function in treatment group treated with NIPPV was significantly improved, the effect of which was better than that in control group(P<0.05).After 2 and 8 hours of therapy, the levels of HR, RR, PaO₂ and SaO₂ in treatment group were better than those in control group(P<0.01).The difference of the PaCO₂ level in treatment group between before treatment and after 2 and 8 hours of therapy was not statistically significant(P>0.05).Compared with the control group, the levels of PaO₂, SaO₂ and CVP in treatment group increased(P<0.05 to P<0.01), and the levels of HR, RR and MAP in treatment group decreased(P<0.05 to P<0.01).The difference of the rehospitalization rate between two groups caused by heart failure was not statistically significant during the six months of following-up(P>0.05).Conclusions:NIPPV can obviously improve the hypoxemia and cardiac function in patients with AHF, which is a kind of safe and effective method in the treatment of AHF.